Search Within

Qing Chang

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (4)
Groups
  1. GSK Faculty (13)
  2. Human Oncology and Pathogenesis Program (13)
  3. Sloan Kettering Institute Postdocs (13)
  4. Tow Center for Developmental Oncology (TCDO) (10)
  5. Department of Medicine (9)
  6. Department of Pathology and Laboratory Medicine (9)

More Groups

People
  1. Elisa De Stanchina (13)
  2. Marc Ladanyi (6)
  3. Inna Khodos (5)
  4. Romel Somwar (5)
  5. Jorge Reis-Filho (4)
  6. Marissa Mattar (4)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (6)
  4. 2021 (2)
  5. 2016 (1)
Publications
  1. Cancer Discovery (2)
  2. Nature Communications (2)
  3. European Journal of Cancer (1)
  4. Journal of Clinical Investigation (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. Nature Publishing Group (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Amer Assoc Advancement Science (1)
  5. American Association for the Advancement of Science (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
    Journal Article

    Mao, N.; Lee, Y. S.; Salsabeel, N.; Zhang, Z.; Li, D.; Kaur, H.; Chen, X.; Chang, Q.; Mehta, S.; Barnes, J.; more...
    Science Advances (2025)

    Fulltext@MSK | Save
  • Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
    Journal Article

    Miyazaki, I.; Odintsov, I.; Ishida, K.; Lui, A. J. W.; Kato, M.; Suzuki, T.; Zhang, T.; Wakayama, K.; Kurth, R. I.; Cheng, R.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Molecular characterization of acquired resistance to KRAS(G12C)–EGFR inhibition in colorectal cancer
    Journal Article

    Yaeger, R.; Mezzadra, R.; Sinopoli, J.; Bian, Y.; Marasco, M.; Kaplun, E.; Gao, H.; Zhao, H. Y.; Paula, A. D. C.; Zhu, Y.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Tractable patient-derived models for preclinical therapeutic studies of CNS metastases
    Meeting Abstract

    Vojnic, M.; Odintsov, I.; Offin, M. D.; Lui, A. J. W.; Khodos, I.; Chang, Q.; Mattar, M. S.; De Stanchina, E.; Ladanyi, M.; Somwar, R.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Ishizawa, K.; Miyazaki, I.; Khodos, I.; Wakayama, K.; Vojnic, M.; Hagen, C. J.; Chang, Q.; Bonifacio, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model
    Meeting Abstract

    Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
    Journal Article

    Strillacci, A.; Sansone, P.; Rajasekhar, V. K.; Turkekul, M.; Boyko, V.; Meng, F.; Houck-Loomis, B.; Brown, D.; Berger, M. F.; Hendrickson, R. C.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • INK4 tumor suppressor proteins mediate resistance to CDK4/6 kinase inhibitors
    Journal Article

    Li, Q.; Jiang, B.; Guo, J.; Shao, H.; Del Priore, I. S.; Chang, Q.; Kudo, R.; Li, Z.; Razavi, P.; Liu, B.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save